Literature DB >> 17076825

Achilles tendon pain intensity and level of neovascularization in athletes as determined by color Doppler ultrasound.

W van Snellenberg1, J P Wiley, G Brunet.   

Abstract

The cause of pain in Achilles tendinopathy is thought to be related to the presence of neovascularization in the tendon as seen on color Doppler ultrasound. Asymptomatic pathology has been observed in patellar tendons of elite athletes. The purpose of this study was to examine the prevalence of Achilles tendon pain and the characteristics of Achilles tendons in a young athletic population. Sixty-four varsity athletes underwent color Doppler ultrasound imaging to determine tendon thickness, presence of degeneration and neovascularization. The presence of swelling and tenderness was determined, and Achilles tendon pain was rated on three visual analogue scales (VAS) (pain during exercise, pain at rest, pain during daily activities) as well as on the VISA-A scale. Tendon symptoms were not related to the presence of neovascularization. There was a low prevalence of Achilles tendinopathy, tenderness, and neovascularization in this population. Neovascularization was seen in both a painful and a non-painful tendon.

Entities:  

Mesh:

Year:  2007        PMID: 17076825     DOI: 10.1111/j.1600-0838.2006.00605.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  9 in total

1.  The victorian institute of sports assessment - achilles questionnaire (visa-a) - a reliable tool for measuring achilles tendinopathy.

Authors:  Jonas Vestergård Iversen; Else Marie Bartels; Henning Langberg
Journal:  Int J Sports Phys Ther       Date:  2012-02

Review 2.  Longitudinal microvascularity in Achilles tendinopathy (power Doppler ultrasound, magnetic resonance imaging time-intensity curves and the Victorian Institute of Sport Assessment-Achilles questionnaire): a pilot study.

Authors:  Paula J Richards; Iain W McCall; Christopher Day; John Belcher; Nicola Maffulli
Journal:  Skeletal Radiol       Date:  2009-08-27       Impact factor: 2.199

3.  In vivo monitoring of angiogenesis during tendon repair: a novel MRI-based technique in a rat patellar tendon model.

Authors:  Richard Stange; Hacer Sahin; Britta Wieskötter; Thorsten Persigehl; Janine Ring; Christoph Bremer; Michael J Raschke; Volker Vieth
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-12       Impact factor: 4.342

4.  WHY ARE ECCENTRIC EXERCISES EFFECTIVE FOR ACHILLES TENDINOPATHY?

Authors:  Seth O'Neill; Paul J Watson; Simon Barry
Journal:  Int J Sports Phys Ther       Date:  2015-08

5.  In vivo photoacoustic micro-imaging of microvascular changes for Achilles tendon injury on a mouse model.

Authors:  Po-Hsun Wang; Jer-Junn Luh; Wen-Shiang Chen; Meng-Lin Li
Journal:  Biomed Opt Express       Date:  2011-05-09       Impact factor: 3.732

6.  A 5-year follow-up study of Alfredson's heel-drop exercise programme in chronic midportion Achilles tendinopathy.

Authors:  A van der Plas; S de Jonge; R J de Vos; H J L van der Heide; J A N Verhaar; A Weir; J L Tol
Journal:  Br J Sports Med       Date:  2011-11-10       Impact factor: 13.800

7.  The interrater reliability of ultrasonography for Achilles tendon structure.

Authors:  Marc Paantjens; Marco Leeuw; Pieter Helmhout; Amanda Isaac; Michel De Maeseneer
Journal:  J Ultrason       Date:  2020-03-31

8.  Using Pressure Massage for Achilles Tendinopathy: A Single-Blind, Randomized Controlled Trial Comparing a Novel Treatment Versus an Eccentric Exercise Protocol.

Authors:  Stefan H Stefansson; Sveinbjörn Brandsson; Henning Langberg; Arni Arnason
Journal:  Orthop J Sports Med       Date:  2019-03-21

9.  In Achilles tendinopathy, the neovascularization, detected by contrast-enhanced ultrasound (CEUS), is abundant but not related to symptoms.

Authors:  Armanda De Marchi; Simona Pozza; Enzo Cenna; Franco Cavallo; Giorgia Gays; Luca Simbula; Paola De Petro; Alessandro Massè; Giuseppe Massazza
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-10-27       Impact factor: 4.342

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.